Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-COVID19 brensocatib versus placebo in hospitalized COVID-19
ISRCTN30564012Phase 3Completed
- Sponsor
- University of Dundee
- Start
- May 2020
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Brensocatib with Placebo (2 arms). Primary endpoint: Participant clinical status on 7-point ordinal scale. Started May 2020; status: completed.
02
Drugs
brensocatib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN30564012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN30564012.